Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02615262Phase 3Completed
A Phase 3 trial of dexamethasone in congenital heart defects (CHD), sponsored by E. Meshalkin National Medical Research Centre. Started Dec 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02615262.